InvestorsHub Logo
Followers 10
Posts 1111
Boards Moderated 0
Alias Born 04/07/2013

Re: Biobillionair post# 70692

Sunday, 01/31/2016 6:44:22 PM

Sunday, January 31, 2016 6:44:22 PM

Post# of 424785
BB I disagree. The drug is priced at $53.6K and will
be discounted to $44K-$46K . This is roughly in line
with GILD's discounted pricing. It is really not
comparable to Sovaldi/Harvoni, as it only treats 2 of
6 genetic sub types of Hep C, GILD's treats all 6. All
of MRK's patients have to be tested for the genetic sub
type.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News